EUVIMEDEUVIMED entdecken
Crossref

Engineering sialylated N-glycans on adeno-associated virus capsids for targeted gene delivery and therapeutic applications

Weixuan Zhao, Jinhuan Luo, Fudi Wang, Yingying Shi, Jiawen Zhang, Yuanjie Zhang, Yingbo Li, Xinchen Wang, Yingying Chen, Xiaohui Zhang, Xiaoyang Wang, Yu Mu und 6 weitere

Journal of Controlled Release · 2025

DOI: 10.1016/j.jconrel.2025.02.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Weixuan Zhao und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; Shenzhen Bay Labor…. Hauptthemen laut MEDLINE: Dependovirus, Capsid, Gene Transfer Techniques, Polysaccharides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Peking University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycans with diverse biological functions have been extensively identified on enveloped viruses, whereas glycosylation on adeno-associated virus (AAV) serotypes remains poorly understood. Identifying potential glycosylation sites on AAVs could provide critical docking sites for rational engineering of AAV capsids, enabling targeted delivery of therapeutic genes. This study presents a strategy that integrates azido-monosaccharide metabolic incorporation, 1,2-diamino-4,5-methylenedioxybenzene-labeled sialic acid analysis, and mass spectrometry to identify N-glycosylation sites and glycoforms on AAVs. We identified sialylated N- oligosaccharides, particularly the conserved NNNS motif, on AAV2, AAV6, AAV7, and AAV9 capsids. These glycans play critical roles in maintaining capsid stability and enhancing resistance to neutralizing antibodies. Furthermore, we engineered an AAV vector with an azido-labeled terminal sialic acid, which was conjugated via click chemistry to cyclic Arg-Gly-Asp (RGD), a high-affinity ligand for integrin αvβ3, to generate an integrin-targeted delivery vehicle. This approach enabled the efficient delivery of c-Met-targeting shRNA in a glioma mouse model and facilitated CRISPR/Cas9-mediated SMOC2 knockout in a mouse model of kidney fibrosis using single-guide RNA (sgRNA). Our findings establish a foundation for creating editable AAV vectors through sialylated termini, thereby expanding their potential applications in basic research and therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusCapsidGene Transfer TechniquesPolysaccharidesN-Acetylneuraminic AcidAnimalsHumansMiceGenetic VectorsGenetic TherapyGlycosylationHEK293 Cells

Stichwörter der Autor:innen

Adeno-associated virusGlycosylationMetabolic glycoengineeringTargeting gene therapy

Substanzen

PolysaccharidesN-Acetylneuraminic Acid

Autor:innen und Institutionen

  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; Shenzhen Bay Laboratory, Gaoke International Innovation Center, Shenzhen, Guangdong 5181…
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Shenzhen Bay Laboratory, Gaoke International Innovation Center, Shenzhen, Guangdong 518107, China; Peking University Ningbo Institute of Marine Medicines, Ningbo, Zhejiang 315832, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; Peking University Ningbo Institute of Marine Medicines, Ningbo, Zhejiang 315832, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; Peking University Ningbo Institute of Marine Medicines, Ningbo, Zhejiang 315832, China;…

Förderung

  • National Natural Science Foundation of China
  • Peking University

Zitieren

APA

Zhao, W., Luo, J., Wang, F., Shi, Y., Zhang, J., Zhang, Y., Li, Y., Wang, X., Chen, Y., Zhang, X., Wang, X., Mu, Y., Ji, D., Xiao, S., Wang, Q., Zhang, L., Zhang, C., & Zhou, D. (2025). Engineering sialylated N-glycans on adeno-associated virus capsids for targeted gene delivery and therapeutic applications. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.02.015

Vancouver

Zhao W, Luo J, Wang F, Shi Y, Zhang J, Zhang Y, et al. Engineering sialylated N-glycans on adeno-associated virus capsids for targeted gene delivery and therapeutic applications. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.02.015

BibTeX
@article{Zhao2025,
  author = {Zhao, Weixuan and Luo, Jinhuan and Wang, Fudi and Shi, Yingying and Zhang, Jiawen and Zhang, Yuanjie and Li, Yingbo and Wang, Xinchen and Chen, Yingying and Zhang, Xiaohui and Wang, Xiaoyang and Mu, Yu and Ji, Dezhong and Xiao, Sulong and Wang, Qi and Zhang, Lihe and Zhang, Chuanling and Zhou, Demin},
  title = {Engineering sialylated N-glycans on adeno-associated virus capsids for targeted gene delivery and therapeutic applications},
  journal = {Journal of Controlled Release},
  year = {2025},
  doi = {10.1016/j.jconrel.2025.02.015}
}
Kostenlos starten →